Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Overview and Management
Establishment Year
2022
Mission
To identify, support, and invest in high-impact early-stage biomedical projects, facilitating their transfer to the market and the National Health System.
Values
Commitment, teamwork, entrepreneurship, humility, quality, passion, excellence, innovation, professionalism, transparency.
Investment Roles
General Partner (GP)
Participant Demographics
Generational Wealth Planning
Risk Tolerance
Focuses on early-stage, high-impact biomedical projects, indicating a moderate-to-high risk tolerance.
References or Case Studies
References include GENESIS Ventures I, which invested in 13 projects and achieved a portfolio valuation multiplier of 3.37.
Team Experience
Managed by GENESIS Biomed, which has a multidisciplinary team with extensive experience in early-stage projects.
Notable Achievements
GENESIS Ventures I invested in 13 projects with a portfolio multiplier of 3.37.
Project Track Record
Investments in early-stage biomedical projects, including Droplite.
Exit Strategies
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
contact@genesis-biomed.eu
Phone Number
+34 93 403 58 53
Address
Barcelona Spain